OBJECTIVE: We investigated the association of vitamin D receptor polymorphisms and colorectal cancer incidence in a Caucasian population. METHODS: Frequencies of the vitamin D receptor gene polymorphisms 23005G>A (CDX-2), 27823C>T (FokI), 60890G>A (BsmI), 61050G>A (Tru9I), 61888G>T (ApaI), and 61968T>C (TaqI) were determined in a series of 256 colorectal cancer patients and 256 patients without malignant disease (case-control study) using polymerase chain reaction and restriction fragment length polymorphism genotyping assays (PCR-RFLP). Haplotype analysis based on the six genetic loci was applied to the received genotypes. RESULTS: Pairwise linkage disequilibrium between BsmI, ApaI, TaqI, and Tru9I was confirmed (P < 0.001). Allele frequencies did not differ between the groups. There was no association between any single variant and colorectal cancer. However, haplotypes BsmI(G)#TaqI(C) and BsmI(A)#TaqI(T) were inversely associated with colorectal cancer incidence (P < 0.001), the odds being 15.0 times smaller [odds ratio (OR) 0.067; 95% confidence interval (CI), 0.016-0.284] and 5.3 times smaller (OR 0.188; 95% CI 0.077-0.461), respectively, compared with noncarriers. CONCLUSION: Our findings suggest that vitamin D receptor haplotypes BsmI(G)#TaqI(C) and BsmI(A)#TaqI(T) have a protective effect against colorectal cancer in Caucasians.
OBJECTIVE: We investigated the association of vitamin D receptor polymorphisms and colorectal cancer incidence in a Caucasian population. METHODS: Frequencies of the vitamin D receptor gene polymorphisms 23005G>A (CDX-2), 27823C>T (FokI), 60890G>A (BsmI), 61050G>A (Tru9I), 61888G>T (ApaI), and 61968T>C (TaqI) were determined in a series of 256 colorectal cancerpatients and 256 patients without malignant disease (case-control study) using polymerase chain reaction and restriction fragment length polymorphism genotyping assays (PCR-RFLP). Haplotype analysis based on the six genetic loci was applied to the received genotypes. RESULTS: Pairwise linkage disequilibrium between BsmI, ApaI, TaqI, and Tru9I was confirmed (P < 0.001). Allele frequencies did not differ between the groups. There was no association between any single variant and colorectal cancer. However, haplotypes BsmI(G)#TaqI(C) and BsmI(A)#TaqI(T) were inversely associated with colorectal cancer incidence (P < 0.001), the odds being 15.0 times smaller [odds ratio (OR) 0.067; 95% confidence interval (CI), 0.016-0.284] and 5.3 times smaller (OR 0.188; 95% CI 0.077-0.461), respectively, compared with noncarriers. CONCLUSION: Our findings suggest that vitamin D receptor haplotypes BsmI(G)#TaqI(C) and BsmI(A)#TaqI(T) have a protective effect against colorectal cancer in Caucasians.
Authors: A G Uitterlinden; A E Weel; H Burger; Y Fang; C M van Duijn; A Hofman; J P van Leeuwen; H A Pols Journal: J Bone Miner Res Date: 2001-02 Impact factor: 6.741
Authors: Bálazs Györffy; Barna Vásárhelyi; Dóra Krikovszky; László Madácsy; Attila Tordai; Tivadar Tulassay; András Szabó Journal: Eur J Endocrinol Date: 2002-12 Impact factor: 6.664
Authors: Pia Sillanpää; Ari Hirvonen; Vesa Kataja; Matti Eskelinen; Veli-Matti Kosma; Matti Uusitupa; Harri Vainio; Katja Mitrunen Journal: Pharmacogenetics Date: 2004-04
Authors: J E Collins; J M Heward; R Nithiyananthan; S Nejentsev; J A Todd; J A Franklyn; S C L Gough Journal: Clin Endocrinol (Oxf) Date: 2004-05 Impact factor: 3.478
Authors: K Douroudis; K Tarassi; G Ioannidis; F Giannakopoulos; P Moutsatsou; N Thalassinos; Chr Papasteriades Journal: Maturitas Date: 2003-07-25 Impact factor: 4.342
Authors: David J Hughes; Ivona Hlavatá; Pavel Soucek; Barbara Pardini; Alessio Naccarati; Ludmila Vodickova; Mazda Jenab; Pavel Vodicka Journal: J Gastrointest Cancer Date: 2011-09
Authors: Jenny N Poynter; Elizabeth T Jacobs; Jane C Figueiredo; Won H Lee; David V Conti; Peter T Campbell; A Joan Levine; Paul Limburg; Loic Le Marchand; Michelle Cotterchio; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; David J Duggan; John A Baron; Robert W Haile Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-01-19 Impact factor: 4.254
Authors: Heather M Ochs-Balcom; Mine S Cicek; Cheryl L Thompson; Thomas C Tucker; Robert C Elston; Sarah J Plummer; Graham Casey; Li Li Journal: Carcinogenesis Date: 2008-07-14 Impact factor: 4.944